The role of the endosomal sorting complexes required for transport (ESCRT) in tumorigenesis

References

• Agromayor M, Martin-Serrano J. 2013. Knowing when to but and run: mechanisms that control cytokinetic abscission. Trends Cell Biol 23:433–441
   PubMed Web of Science ®Google Scholar
• Babst M. 2005. A protein’s final ESCRT. Traffic 6:2–9
   PubMed Web of Science ®Google Scholar
• Babst M, Odorizzi G, Estepa EJ, Emr SD. 2000. Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking. Traffic 1:248–258
   PubMed Web of Science ®Google Scholar
• Bache KG, Stuffers S, Malerod L, Slagsvold T, Raiborg C, Lechardeur D, et al. 2006. The ESCRT-III subunit hVps24 is required for degradation but not silencing of the epidermal growth factor receptor. Mol Biol Cell 17:2513–2523
   Google Scholar
• Bankaitis VA, Johnson LM, Emr SD. 1986. Isolation of yeast mutants defective in protein targeting to the vacuole. Proc Natl Acad Sci USA 83:9075–9079
   PubMed Web of Science ®Google Scholar
• Bishop N, Woodman P. 2001. TSG101/mammalian Vps23 and mammalian Vps28 interact directly and are recruited to Vps4-induced endosomes. J Biol Chem 276:11735–11742
   PubMed Web of Science ®Google Scholar
• Boyer B, Valles AM, Tucker GC, Delouvee A, Thiery JP. 1993. Involvement of cell motility in tumor progression. Symp Soc Experim Biol 47:183–195
   Google Scholar
• Brankatschk B, Wichert SP, Johnson SD, Schaad O, Rossner MJ, Gruenberg J. 2012. Regulation of the EGF transcriptional response by endocytic sorting. Sci Signal 5:ra21
   PubMedGoogle Scholar
• Brown CJ, Lain S, Verma CS, Fersht AR, Lane DP. 2009. Awakening guardian angels: drugging the p53 pathway. Nature Rev Cancer 9:862–873
   PubMed Web of Science ®Google Scholar
• Cai C, Zhang D, Lu P, Gao Y, Chang J. 2008. Expression and its significance of TSG101 in lung cancer tissue and lung cancer cell lines. Chin J Lung Cancer 11:172–177
   Google Scholar
• Carlton JG, Caballe A, Agromayor M, Kloc M, Martin-Serrano J. 2012. ESCRT-III governs the Aurora B-mediated abscission checkpoint through CHMP4C. Science 336:220–225
   PubMed Web of Science ®Google Scholar
• Carlton JG, Martin-Serrano J. 2007. Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. Science 316:1908–1912
   PubMed Web of Science ®Google Scholar
• Carney ME, Maxwell GL, Lancaster JM, Gumbs C, Marks J, Berchuck A, Futreal PA. 1998. Aberrant splicing of the TSG101 tumor suppressor gene in human breast and ovarian cancers. J Soc Gynecolog Investig 5:281–285
   PubMedGoogle Scholar
• Carstens MJ, Krempler A, Triplett AA, Van Lohuizen M, Wagner KU. 2004. Cell cycle arrest and cell death are controlled by p53-dependent and p53-independent mechanisms in Tsg101-deficient cells. J Biolog Chem 279:35984–35994
   PubMedGoogle Scholar
• Daniels MJ, Wang Y, Lee M, Venkitaraman AR. 2004. Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2. Science 306:876–879
   PubMed Web of Science ®Google Scholar
• Dukes JD, Fish L, Richardson JD, Blaikley E, Burns S, Caunt CJ, et al. 2011. Functional ESCRT machinery is required for constitutive recycling of claudin-1 and maintenance of polarity in vertebrate epithelial cells. Mol Biol Cell 22:3192–3205
   PubMed Web of Science ®Google Scholar
• Foulkes WD, Shuen AY. 2013. In brief: BRCA1 and BRCA2. J Pathol 230:347–349
   Google Scholar
• Garrus JE, Von Schwedler UK, Pornillos OW, Morham SG, Zavitz KH, Wang HE, et al. 2001. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107:55–65
   PubMed Web of Science ®Google Scholar
• Gotzmann J, Mikula M, Eger A, Schulte-Hermann R, Foisner R, Beug H, Mikulits W. 2004. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat Res 566:9–20
   PubMed Web of Science ®Google Scholar
• Hanson PI, Cashikar A. 2012. Multivesicular body morphogenesis. Annu Rev Cell Dev Biol 28:337–362
   PubMed Web of Science ®Google Scholar
• Henne WM, Buchkovich NJ, Emr SD. 2011. The ESCRT pathway. Develop Cell 21:77–91
   PubMed Web of Science ®Google Scholar
• Herz HM, Chen Z, Scherr H, Lackey M, Bolduc C, Bergmann A. 2006. Vps25 mosaics display non-autonomous cell survival and overgrowth, and autonomous apoptosis. Development 133:1871–1880
   PubMed Web of Science ®Google Scholar
• Jiang Y, Ou Y, Cheng X. 2013. Role of TSG101 in cancer. Front Biosci 18:279–288
   Google Scholar
• Jones CB, Ott EM, Keener JM, Curtiss M, Sandrin V, Babst M. 2012. Regulation of membrane protein degradation by starvation-response pathways. Traffic 13:468–482
   PubMed Web of Science ®Google Scholar
• Katzmann DJ, Babst M, Emr SD. 2001. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell 106:145–155
   PubMed Web of Science ®Google Scholar
• Komada M, Soriano P. 1999. Hrs, a FYVE finger protein localized to early endosomes, is implicated in vesicular traffic and required for ventral folding morphogenesis. Genes Develop 13:1475–1485
   PubMedGoogle Scholar
• Krempler A, Henry MD, Triplett AA, Wagner KU. 2002. Targeted deletion of the Tsg101 gene results in cell cycle arrest at G1/S and p53-independent cell death. J Biol Chem 277:43216–43223
   PubMed Web of Science ®Google Scholar
• Lekomtsev S, Guizetti J, Pozniakovsky A, Gerlich DW, Petronczki M. 2010. Evidence that the tumor-suppressor protein BRCA2 does not regulate cytokinesis in human cells. J Cell Sci 123:1395–1400
   Google Scholar
• Leung KF, Dacks JB, Field MC. 2008. Evolution of the multivesicular body ESCRT machinery; retention across the eukaryotic lineage. Traffic 9:1698–1716
   Google Scholar
• Li J, Belogortseva N, Porter D, Park M. 2008. Chmp1A functions as a novel tumor suppressor gene in human embryonic kidney and ductal pancreatic tumor cells. Cell Cycle 7:2886–2893
   PubMed Web of Science ®Google Scholar
• Li L, Cohen SN. 1996. Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell 85:319–329
   PubMed Web of Science ®Google Scholar
• Li L, Francke U, Cohen SN. 1998. Retraction. The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell 93:following 660
   Google Scholar
• Li L, Li X, Francke U, Cohen SN. 1997. The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell 88:143–154
   PubMed Web of Science ®Google Scholar
• Li L, Liao J, Ruland J, Mak TW, Cohen SN. 2001. A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control. Proc Natl Acad Sci USA 98:1619–1624
   PubMedGoogle Scholar
• Liao Z, Thomas SN, Wan Y, Lin HH, Ann DK, Yang AJ. 2013. An internal standard-assisted synthesis and degradation proteomic approach reveals the potential linkage between Vps4B depletion and activation of fatty acid beta-oxidation in breast cancer cells. Int J Proteom 2013:291415
   Google Scholar
• Lin HH, Li X, Chen JL, Sun X, Cooper FN, Chen YR, et al. 2012. Identification of an AAA ATPase Vps4B-dependent pathway that modulates epidermal growth factor receptor abundance and signaling during hypoxia. Mol Cell Biol 32:1124–1138
   PubMedGoogle Scholar
• Lindas AC, Karlsson EA, Lindgren MT, Ettema TJ, Bernander R. 2008. A unique cell division machinery in the Archaea. Proc Natl Acad Sci USA 105:18942–18946
   PubMed Web of Science ®Google Scholar
• Liu F, Yu Y, Jin Y, Fu S. 2010. TSG101, identified by screening a cancer cDNA library and soft agar assay, promotes cell proliferation in human lung cancer. Mol Biol Rep 37:2829–2838
   Google Scholar
• Liu RT, Huang CC, You HL, Chou FF, Hu CC, Chao FP, et al. 2002. Overexpression of tumor susceptibility gene TSG101 in human papillary thyroid carcinomas. Oncogene 21:4830–4837
   PubMed Web of Science ®Google Scholar
• Lloyd TE, Atkinson R, Wu MN, Zhou Y, Pennetta G, Bellen HJ. 2002. Hrs regulates endosome membrane invagination and tyrosine kinase receptor signaling in Drosophila. Cell 108:261–269
   PubMed Web of Science ®Google Scholar
• Lobert VH, Brech A, Pedersen NM, Wesche J, Oppelt A, Malerod L, Stenmark H. 2010. Ubiquitination of alpha 5 beta 1 integrin controls fibroblast migration through lysosomal degradation of fibronectin-integrin complexes. Develop Cell 19:148–159
   PubMed Web of Science ®Google Scholar
• Lu H, Bilder D. 2005. Endocytic control of epithelial polarity and proliferation in Drosophila. Nature Cell Biol 7:1232–1239
   PubMedGoogle Scholar
• Lu P, Zhang D, Gao Y, Hu C. 2007. Expression and significance of TSG101, P21 and P300/CBP in squamous cell carcinoma and adenocarcinoma of the lung. Chin J Lung Cancer 10:197–202
   Google Scholar
• Ma XR, Edmund Sim UH, Pauline B, Patricia L, Rahman J. 2008. Overexpression of WNT2 and TSG101 genes in colorectal carcinoma. Trop Biomed 25:46–57
   PubMed Web of Science ®Google Scholar
• Malerod L, Stuffers S, Brech A, Stenmark H. 2007. Vps22/EAP30 in ESCRT-II mediates endosomal sorting of growth factor and chemokine receptors destined for lysosomal degradation. Traffic 8:1617–1629
   PubMedGoogle Scholar
• Martin-Serrano J, Zang T, Bieniasz PD. 2001. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nature Med 7:1313–1319
   PubMed Web of Science ®Google Scholar
• Martin-Serrano J, Zang T, Bieniasz PD. 2003. Role of ESCRT-I in retroviral budding. J Virol 77:4794–4804
   PubMed Web of Science ®Google Scholar
• McCullough J, Colf LA, Sundquist WI. 2013. Membrane fission reactions of the mammalian ESCRT pathway. Annu Rev Biochem 82:663–692
   PubMed Web of Science ®Google Scholar
• Moberg KH, Schelble S, Burdick SK, Hariharan IK. 2005. Mutations in erupted, the Drosophila ortholog of mammalian tumor susceptibility gene 101, elicit non-cell-autonomous overgrowth. Develop Cell 9:699–710
   PubMed Web of Science ®Google Scholar
• Mochida GH, Ganesh VS, De Michelena MI, Dias H, Atabay KD, Kathrein KL, et al. 2012. CHMP1A encodes an essential regulator of BMI1-INK4A in cerebellar development. Nature Genet 44:1260–1264
   Google Scholar
• Mondal G, Rowley M, Guidugli L, Wu J, Pankratz VS, Couch FJ. 2012. BRCA2 localization to the midbody by filamin A regulates cep55 signaling and completion of cytokinesis. Develop Cell 23:137–152
   PubMed Web of Science ®Google Scholar
• Morita E, Sandrin V, Chung HY, Morham SG, Gygi SP, Rodesch CK, Sundquist WI. 2007. Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis. EMBO J 26:4215–4227
   PubMed Web of Science ®Google Scholar
• Morris CR, Stanton MJ, Manthey KC, Oh KB, Wagner KU. 2012. A knockout of the Tsg101 gene leads to decreased expression of ErbB receptor tyrosine kinases and induction of autophagy prior to cell death. PLoS One 7:e34308
   Web of Science ®Google Scholar
• Mosesson Y, Mills GB, Yarden Y. 2008. Derailed endocytosis: an emerging feature of cancer. Nat Rev Cancer 8:835–850
   PubMed Web of Science ®Google Scholar
• Nikolova DN, Doganov N, Dimitrov R, Angelov K, Low SK, Dimova I, Toncheva D, et al. 2009. Genome-wide gene expression profiles of ovarian carcinoma: identification of molecular targets for the treatment of ovarian carcinoma. Molec Med Rep 2:365–384
   Google Scholar
• Odorizzi G, Babst M, Emr SD. 1998. Fab1p PtdIns(3)P 5-kinase function essential for protein sorting in the multivesicular body. Cell 95:847–858
   PubMed Web of Science ®Google Scholar
• Oh KB, Stanton MJ, West WW, Todd GL, Wagner KU. 2007. Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation. Oncogene 26:5950–5959
   PubMed Web of Science ®Google Scholar
• Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, et al. 2013. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nature Genet 45:362–370, 370e1–2
   Google Scholar
• Qian J, Zhang XH, Yang JB, Wang JR, Zhang BC, Tang K, Li GY. 2001. Cloning and expression analysis of a novel gene, UBAP1, possibly involved in ubiquitin pathway. Acta Biochim Biophys Sinica 33:147–152
   Google Scholar
• Raiborg C, Malerod L, Pedersen NM, Stenmark H. 2008. Differential functions of Hrs and ESCRT proteins in endocytic membrane trafficking. Exp Cell Res 314:801–813
   PubMedGoogle Scholar
• Raymond CK, Howald-Stevenson I, Vater CA, Stevens TH. 1992. Morphological classification of the yeast vacuolar protein sorting mutants: evidence for a prevacuolar compartment in class E vps mutants. Mol Biol Cell 3:1389–1402
   PubMed Web of Science ®Google Scholar
• Rothman JH, Stevens TH. 1986. Protein sorting in yeast: mutants defective in vacuole biogenesis mislocalize vacuolar proteins into the late secretory pathway. Cell 47:1041–1051
   PubMed Web of Science ®Google Scholar
• Ruland J, Sirard C, Elia A, Macpherson D, Wakeham A, Li L, et al. 2001. p53 accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101. Proc Natl Acad Sci USA 98:1859–1864
   PubMed Web of Science ®Google Scholar
• Rusten TE, Vaccari T, Stenmark H. 2012. Shaping development with ESCRTs. Nature Cell Biol 14:38–45
   PubMed Web of Science ®Google Scholar
• Sagona AP, Stenmark H. 2010. Cytokinesis and cancer. FEBS Lett 584:2652–2661
   PubMed Web of Science ®Google Scholar
• Samson RY, Obita T, Freund SM, Williams RL, Bell SD. 2008. A role for the ESCRT system in cell division in archaea. Science 322:1710–1713
   PubMed Web of Science ®Google Scholar
• Schmidt O, Teis D. 2012. The ESCRT machinery. Curr Biol 22:R116–120
   PubMed Web of Science ®Google Scholar
• Scoles DR, Qin Y, Nguyen V, Gutmann DH, Pulst SM. 2005. HRS inhibits EGF receptor signaling in the RT4 rat schwannoma cell line. Biochem Biophys Res Commun 335:385–392
   Google Scholar
• Spitzer C, Schellmann S, Sabovljevic A, Shahriari M, Keshavaiah C, Bechtold N, et al. 2006. The Arabidopsis elch mutant reveals functions of an ESCRT component in cytokinesis. Development 133:4679–4689
   Google Scholar
• Stefani F, Zhang L, Taylor S, Donovan J, Rollinson S, Doyotte A, et al. 2011. UBAP1 is a component of an endosome-specific ESCRT-I complex that is essential for MVB sorting. Curr Biol 21:1245–1250
   Google Scholar
• Steiner P, Barnes DM, Harris WH, Weinberg RA. 1997. Absence of rearrangements in the tumour susceptibility gene TSG101 in human breast cancer. Nature Genet 16:332–333
   PubMed Web of Science ®Google Scholar
• Théry C. 2011. Exosomes: secreted vesicles and intercellular communications. F1000 Biol Rep 3:15
   PubMedGoogle Scholar
• Thompson BJ, Mathieu J, Sung HH, Loeser E, Rorth P, Cohen SM. 2005. Tumor suppressor properties of the ESCRT-II complex component Vps25 in Drosophila. Develop Cell 9:711–720
   PubMed Web of Science ®Google Scholar
• Toyoshima M, Tanaka N, Aoki J, Tanaka Y, Murata K, Kyuuma M, et al. 2007. Inhibition of tumor growth and metastasis by depletion of vesicular sorting protein Hrs: its regulatory role on E-cadherin and beta-catenin. Cancer Res 67:5162–5171
   PubMed Web of Science ®Google Scholar
• Tu C, Ortega-Cava CF, Winograd P, Stanton MJ, Reddi AL, Dodge I, et al. 2010. Endosomal-sorting complexes required for transport (ESCRT) pathway-dependent endosomal traffic regulates the localization of active Src at focal adhesions. Proc Natl Acad Sci USA 107:16107–16112
   PubMed Web of Science ®Google Scholar
• Urbe S, Sachse M, Row PE, Preisinger C, Barr FA, Strous G, et al. 2003. The UIM domain of Hrs couples receptor sorting to vesicle formation. J Cell Sci 116:4169–4179
   PubMedGoogle Scholar
• Vaccari T, Bilder D. 2005. The Drosophila tumor suppressor Vps25 prevents nonautonomous overproliferation by regulating notch trafficking. Develop Cell 9:687–698
   PubMed Web of Science ®Google Scholar
• Vaccari T, Rusten TE, Menut L, Nezis IP, Brech A, Stenmark H, Bilder D. 2009. Comparative analysis of ESCRT-I, ESCRT-II and ESCRT-III function in Drosophila by efficient isolation of ESCRT mutants. J Cell Sci 122:2413–2423
   PubMed Web of Science ®Google Scholar
• Verplank L, Bouamr F, Lagrassa TJ, Agresta B, Kikonyogo A, Leis J, Carter CA. 2001. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc Natl Acad Sci USA 98:7724–7729
   PubMed Web of Science ®Google Scholar
• Von Schwedler UK, Stuchell M, Muller B, Ward DM, Chung HY, Morita E, et al. 2003. The protein network of HIV budding. Cell 114:701–713
   PubMed Web of Science ®Google Scholar
• Votteler J, Sundquist WI. 2013. Virus budding and the ESCRT pathway. Cell Host Microbe 14:232–241
   Google Scholar
• Wagner KU, Krempler A, Qi Y, Park K, Henry MD, Triplett AA, et al. 2003. Tsg101 is essential for cell growth, proliferation, and cell survival of embryonic and adult tissues. Mol Cell Biol 23:150–162
   PubMed Web of Science ®Google Scholar
• Walker GE, Antoniono RJ, Ross HJ, Paisley TE, Oh Y. 2006. Neuroendocrine-like differentiation of non-small cell lung carcinoma cells: regulation by cAMP and the interaction of mac25/IGFBP-rP1 and 25.1. Oncogene 25:1943–1954
   Google Scholar
• Wilson EM, Oh Y, Hwa V, Rosenfeld RG. 2001. Interaction of IGF-binding protein-related protein 1 with a novel protein, neuroendocrine differentiation factor, results in neuroendocrine differentiation of prostate cancer cells. J Clin Endocrinol Metabol 86:4504–4511
   Google Scholar
• Wittinger M, Vanhara P, El-Gazzar A, Savarese-Brenner B, Pils D, Anees M, et al. 2011. hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancer. Clin Cancer Res 17:7816–7827
   Google Scholar
• Woodfield SE, Graves HK, Hernandez JA, Bergmann A. 2013. De-regulation of JNK and JAK/STAT signaling in ESCRT-II mutant tissues cooperatively contributes to neoplastic tumorigenesis. PLoS One 8:e56021
   Google Scholar
• Xiao B, Fan S, Zeng Z, Xiong W, Cao L, Yang Y, et al. 2006. Purification of novel UBAP1 protein and its decreased expression on nasopharyngeal carcinoma tissue microarray. Protein Expres Purificat 47:60–67
   Google Scholar
• Xu Z, Liang L, Wang H, Li T, Zhao M. 2003. HCRP1, a novel gene that is downregulated in hepatocellular carcinoma, encodes a growth-inhibitory protein. Biochem Biophys Res Commun 311:1057–1066
   Google Scholar
• Yamada M, Ishii N, Asao H, Murata K, Kanazawa C, Sasaki H, Sugamura K. 2002. Signal-transducing adaptor molecules STAM1 and STAM2 are required for T-cell development and survival. Mol Cell Biol 22:8648–8658
   PubMedGoogle Scholar
• Young TW, Mei FC, Rosen DG, Yang G, Li N, Liu J, Cheng X. 2007a. Up-regulation of tumor susceptibility gene 101 protein in ovarian carcinomas revealed by proteomics analyses. Mol Cell Proteom 6:294–304
   Google Scholar
• Young TW, Rosen DG, Mei FC, Li N, Liu J, Wang XF, Cheng X. 2007b. Up-regulation of tumor susceptibility gene 101 conveys poor prognosis through suppression of p21 expression in ovarian cancer. Clin Cancer Res 13:3848–3854
   PubMed Web of Science ®Google Scholar
• Zhang Y, Song M, Cui ZS, Li CY, Xue XX, Yu M, et al. 2011. Down-regulation of TSG101 by small interfering RNA inhibits the proliferation of breast cancer cells through the MAPK/ERK signal pathway. Histol Histopathol 26:87–94
   PubMed Web of Science ®Google Scholar
• Zheng ZY, Cheng CM, Fu XR, Chen LY, Xu L, Terrillon S, et al. 2012. CHMP6 and Vps4A mediate the recycling of Ras to the plasma membrane to promote growth factor signaling. Oncogene 31:4630–4638
   PubMedGoogle Scholar
• Zhu G, Gilchrist R, Borley N, Chng HW, Morgan M, Marshall JF, et al. 2004. Reduction of TSG101 protein has a negative impact on tumor cell growth. Int J Cancer 109:541–547
   PubMed Web of Science ®Google Scholar
• Zivony-Elboum Y, Westbroek W, Kfir N, Savitzki D, Shoval Y, Bloom A, et al. 2012. A founder mutation in Vps37A causes autosomal recessive complex hereditary spastic paraparesis. J Medic Genet 49:462–472
   PubMed Web of Science ®Google Scholar